Blueprint Medicines Corporation and Proteovant Therapeutics announced a strategic collaboration to advance novel targeted protein degrader therapies to address important areas of medical need....
Boston Scientific Corporation announced positive results from a new analysis assessing real-world outcomes with the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device. Presented...
Medical Guardian, a leading provider of personal emergency response systems (PERS), announced the release of its new medical alert smartwatch — the MGMove. The...
BIOTRONIK is pleased to announce five-year data from the BIOFLOW-V trial, which was presented yesterday at the 2022 CRT Conference during a late-breaking clinical...
